Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Infection and inflammation is related to increased encephalopathy of prematurities.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
• Treatments: gamma-Globulins; Immunoglobulins, Intravenous; Rho(D) Immune Globulin

Criteria

Inclusion Criteria:

• preterm infants with encephalopathy

Exclusion Criteria:

• refuse the participate in the trial